AliveCor and Thomas Jefferson University Hospital Partner to Evaluate KardiaMobile 6L for QT Prolongation Screening in Patients Treated for Opioid Use Disorder
Similar Posts
HHAeXchange Homecare Survey:
80% of Caregivers Say Impact On Patient
Health and Well-Being is Their #1 MotivatorDespite challenges with workforce shortages, burnout, and pay, new survey finds that caregivers remain motivated by their work and…
Health Systems Advance AI, Partnerships, and Innovation in 2026
New collaborations, technology deployments, and leadership changes mark a period of rapid transformation Healthcare organizations across the United States…
Survey says: Women are skipping cancer screenings during pandemic, but they plan to get ‘back on the books’
September and October bring focus on women’s health through gynecologic and breast cancer awareness The COVID-19 pandemic has increased…
Blue Shield of California Expands Collaboration with Dignity Health Hospitals to Make Billing and Payment Easier for Patients, Providers
Innovative program expands to 26 facilities throughout California to better support providers during COVID-19 Blue Shield of California announced the…
